Interface Pharmaceuticals Pvt Ltd, a active private limited company, was established on 14 June 1999 in New Delhi, Delhi, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24232DL1999PTC100229. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Sudhir Kumar Malhotra (Director), Shilpa Malhotra (Director), Promila Malhotra (Director). Past directors included Manan Malhotra. It holds ₹7.95 M open charges and ₹1.55 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Ea-180, Maya Enclave, New Delhi, Delhi, 110064.
U24232DL1999PTC100229
100229
14 June 1999
₹1.00 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Interface Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudhir Kumar Malhotra | Director | 14 Jun 1999 | Current |
| Shilpa Malhotra | Director | 20 Oct 2019 | Current |
| Promila Malhotra | Director | 14 Jun 1999 | Current |
| Manan Malhotra | Director | 25 Jul 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 28 Mar 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Interface Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 57.91% increase. The company also saw a substantial improvement in profitability, with a 98.9% increase in profit. The company's net worth Soared by an impressive increase of 53.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Interface Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,950,000.00
₹1,550,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2023 | Hdfc Bank Limited | ₹7.95 M | Open |
| 22 Nov 2008 | The Nainital Bank Limited | ₹0.90 M | Satisfied |
| 20 Sep 2004 | The Nainital Bank | ₹0.65 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Interface Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Interface Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Interface Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Interface Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Interface Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 7.95 M with Charge ID 100820948 was registered on 18 Sep 2023. was recorded as a recent event.
The activity A charge registered on 22 Nov 2008 via Charge ID 10132572 with The Nainital Bank Limited was fully satisfied on 15 Sep 2022. was completed.
The activity Manan Malhotra was appointed as a Director was appointed as a Director on 25 Jul 2022 & has been associated with this company since 3 years 4 months . was completed.
The activity Shilpa Malhotra was appointed as a Director was appointed as a Director on 20 Oct 2019 & has been associated with this company since 6 years 1 month . was completed.
The CIN of Interface Pharmaceuticals Pvt Ltd is U24232DL1999PTC100229.
Interface Pharmaceuticals Pvt Ltd is headquartered at Ea-180, Maya Enclave, New Delhi, Delhi, 110064.
Interface Pharmaceuticals Pvt Ltd was incorporated on 14 June 1999.
The current directors of Interface Pharmaceuticals Pvt Ltd are
The primary industry of Interface Pharmaceuticals Pvt Ltd is Manufacturing.
Interface Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Interface Pharmaceuticals Pvt Ltd is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Interface Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX